Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Mutant superoxide dismutase disrupts cytoplasmic dynein in motor neurons.
Neuroreport. 2005 Apr 25;16(6):533-6. doi: 10.1097/00001756-200504250-00002.
Neuroreport. 2005.
PMID: 15812301
Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration.
LaMonte BH, Wallace KE, Holloway BA, Shelly SS, Ascaño J, Tokito M, Van Winkle T, Howland DS, Holzbaur EL.
LaMonte BH, et al.
Neuron. 2002 May 30;34(5):715-27. doi: 10.1016/s0896-6273(02)00696-7.
Neuron. 2002.
PMID: 12062019
Free article.
Item in Clipboard
A motor neuron disease-associated mutation in p150Glued perturbs dynactin function and induces protein aggregation.
Levy JR, Sumner CJ, Caviston JP, Tokito MK, Ranganathan S, Ligon LA, Wallace KE, LaMonte BH, Harmison GG, Puls I, Fischbeck KH, Holzbaur EL.
Levy JR, et al. Among authors: lamonte bh.
J Cell Biol. 2006 Feb 27;172(5):733-45. doi: 10.1083/jcb.200511068.
J Cell Biol. 2006.
PMID: 16505168
Free PMC article.
Item in Clipboard
Characterization of the p22 subunit of dynactin reveals the localization of cytoplasmic dynein and dynactin to the midbody of dividing cells.
Karki S, LaMonte B, Holzbaur EL.
Karki S, et al.
J Cell Biol. 1998 Aug 24;142(4):1023-34. doi: 10.1083/jcb.142.4.1023.
J Cell Biol. 1998.
PMID: 9722614
Free PMC article.
Item in Clipboard
Mutant dynactin in motor neuron disease.
Puls I, Jonnakuty C, LaMonte BH, Holzbaur EL, Tokito M, Mann E, Floeter MK, Bidus K, Drayna D, Oh SJ, Brown RH Jr, Ludlow CL, Fischbeck KH.
Puls I, et al. Among authors: lamonte bh.
Nat Genet. 2003 Apr;33(4):455-6. doi: 10.1038/ng1123. Epub 2003 Mar 10.
Nat Genet. 2003.
PMID: 12627231
Item in Clipboard
Treatment with pergolide or cyproheptadine of pituitary pars intermedia dysfunction (equine Cushing's disease).
Donaldson MT, LaMonte BH, Morresey P, Smith G, Beech J.
Donaldson MT, et al. Among authors: lamonte bh.
J Vet Intern Med. 2002 Nov-Dec;16(6):742-6. doi: 10.1892/0891-6640(2002)016<0742:twpoco>2.3.co;2.
J Vet Intern Med. 2002.
PMID: 12465775
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite